loading

Finanzdaten der Senti Biosciences Inc-Aktie (SNTI)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
0.89%
16.95
16.80 16.40 16.17 15.21
Operating Income/Loss
0.89%
-16.95
-16.80 -16.40 -16.17 -15.21
Nonoperating Income/Loss
157.05%
-1.178
2.065 2.285 15.56 -13.65
Income/Loss From Continuing Operations Before Tax
23.03%
-18.13
-14.73 -14.11 -0.61 -28.87
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
23.03%
-18.13
-14.73 -14.11 -0.61 -28.87
Net Income/Loss
23.03%
-18.13
-14.73 -14.11 -0.61 -28.87
Preferred Stock Dividends And Other Adjustments
-
- - 2.522 -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.56%
26.23
26.08 10.01 0.0226 4.5771
Diluted Average Shares
0.56%
26.23
26.08 10.01 0.0226 4.5771
Basic Earnings Per Share
23.21%
-0.69
-0.56 -1.41 -0.62 -6.31
Diluted Earnings Per Share
23.21%
-0.69
-0.56 -1.41 -0.62 -6.31
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - 2.522 -
$53.93
price down icon 0.19%
$48.83
price down icon 0.66%
$99.82
price up icon 0.63%
$152.54
price up icon 0.01%
$145.58
price down icon 4.81%
ONC ONC
$323.57
price up icon 3.77%
Kapitalisierung:     |  Volumen (24h):